EOLS
Evolus, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website evolus.com
- Employees(FY) 246
- ISIN US30052C1071
Performance
-5.96%
1W
-12.11%
1M
-33.76%
3M
+2.35%
6M
+3.42%
YTD
+12.5%
1Y
Profile
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It serves self-pay aesthetic healthcare market. Evolus, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
Technical Analysis of EOLS 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-20 05:39
Evolus, Inc.'s (NASDAQ:EOLS) Path To Profitability(Simply Wall St.)
- 2024-12-13 16:05
- 2024-12-13 03:05
- 2024-11-18 09:55
- 2024-11-14 09:35
- 2024-11-09 09:23
- 2024-11-08 06:10
Evolus Third Quarter 2024 Earnings: Misses Expectations(Simply Wall St.)
- 2024-11-07 06:00
- 2024-11-06 18:25
- 2024-11-06 16:05
Evolus Reports Third Quarter 2024 Results(Business Wire)
- 2024-11-06 03:05
Evolus Reports Third Quarter 2024 Results(Businesswire)
- 2024-11-01 08:00
Evolus to Participate in Stifel 2024 Healthcare Conference(Business Wire)
- 2024-10-31 20:00
- 2024-10-31 15:08
- 2024-10-31 14:02
- 2024-10-31 10:02
- 2024-10-31 02:02
- 2024-10-30 10:01
- 2024-10-29 08:00
- 2024-10-28 20:00
- 2024-10-23 08:00
- 2024-10-22 20:00
- 2024-10-11 22:53
- 2024-10-11 10:53
- 2024-10-10 11:29
- 2024-10-09 15:36
- 2024-09-27 21:00
- 2024-09-27 09:00
- 2024-09-06 08:00
- 2024-09-05 20:00
Page 1 of 8
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.